SEC Form 4 · accession 0001209191-15-081587
U S PHYSICAL THERAPY INC /NV · USPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher J Reading
Officer — Chief Executive Officer · Director
Period of report
Nov 19, 2015
Accepted (ET)
Nov 20, 2015 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885978
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stockF1,F2 | Nov 19, 2015 | S | 21,848 | $52.13 | D | 97,309 | D | |
| Common StockF3,F2 | Nov 20, 2015 | S | 3,152 | $52.08 | D | 94,157 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.01 - $52.70, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- F2Includes 62,330 restricted shares granted under the Company's equity plans for which restrictions have not lapsed. Restrictions lapse as to 6675 on January 1, 2016, April 1, 2016, July 1, 2016, October 1, 2016, January 1, 2017, 4375 on April 1, 2017, July 1, 2017, October 1, 2017 and January 1, 2018; and 1455 on December 31, 2015; 2500 on April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019.
- F3The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.00 - $52.46, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.